NOW AVAILABLE on the APP Store and Google Play: The Lesion Area Mapping Assistant (LAMA) is Thalocan’s cloud-based solution for enhancing lesion assessment in dermatologic clinical trials. Investigators can securely capture clinical images, map lesions, and document severity assessments using their own device or a study-provided tablet. LAMA enables real-time data sharing among investigators, CROs,…
June is Myasthenia Gravis (MG) Awareness Month. This annual campaign is designed to increase public understanding of this neuromuscular autoimmune disease, support those living with it, and raise funds for research. Here at Thalocan Research Innovations. we were proud to partner with Dr. Richard Barohn, Dr. Gil Wolfe and Instructor Laura Herbelin in creating Thalocan’s…
Eric Zudak, CEO of Thalocan Research Innovations, discusses Thalocan’s role in helping to address unmet needs in the immunodermatology area. With many, if not most inflammatory skin diseases being more common in Skin of Color than in lighter pigmented skin – Thalocan is proud to provide cutting edge technology, training and tools for more accurate scientific…
Meet (most) of the Thalocan Research Innovations team at SHSA 2025 in Nashville, the 10th annual symposium on Hidradenitis Supprativa. Here at TRI we are working alongside a number of KOLs including Dr. Amit Garg and Professor John Ingram, in creating technology and training to improve clinical trials and aid in the assessment and…
